TCW Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,719
| Closed | -$439K | – | 342 |
|
|
2018
Q3 | $439K | Sell |
1,719
-1
| -0.1% | -$255 | ﹤0.01% | 307 |
|
|
2018
Q2 | $438K | Sell |
1,720
-1,177
| -41% | -$300K | ﹤0.01% | 301 |
|
|
2018
Q1 | $583K | Buy |
2,897
+187
| +7% | +$37.6K | ﹤0.01% | 297 |
|
|
2017
Q4 | $390K | Hold |
2,710
| – | – | ﹤0.01% | 355 |
|
|
2017
Q3 | $446K | Hold |
2,710
| – | – | ﹤0.01% | 357 |
|
|
2017
Q2 | $368K | Hold |
2,710
| – | – | ﹤0.01% | 370 |
|
|
2017
Q1 | $522K | Hold |
2,710
| – | – | ﹤0.01% | 354 |
|
|
2016
Q4 | $382K | Hold |
2,710
| – | – | ﹤0.01% | 650 |
|
|
2016
Q3 | $396K | Sell |
2,710
-67
| -2% | -$9.79K | ﹤0.01% | 622 |
|
|
2016
Q2 | $279K | Hold |
2,777
| – | – | ﹤0.01% | 664 |
|
|
2016
Q1 | $372K | Sell |
2,777
-222
| -7% | -$29.7K | ﹤0.01% | 654 |
|
|
2015
Q4 | $596K | Buy |
2,999
+167
| +6% | +$33.2K | ﹤0.01% | 615 |
|
|
2015
Q3 | $447K | Sell |
2,832
-1,334
| -32% | -$211K | ﹤0.01% | 648 |
|
|
2015
Q2 | $1.7M | Sell |
4,166
-5,093
| -55% | -$2.08M | 0.01% | 424 |
|
|
2015
Q1 | $4.25M | Sell |
9,259
-1,944
| -17% | -$893K | 0.02% | 420 |
|
|
2014
Q4 | $6.29M | Buy |
11,203
+2,063
| +23% | +$1.16M | 0.03% | 350 |
|
|
2014
Q3 | $4.79M | Buy |
9,140
+1,004
| +12% | +$526K | 0.02% | 495 |
|
|
2014
Q2 | $5.68M | Sell |
8,136
-231
| -3% | -$161K | 0.02% | 459 |
|
|
2014
Q1 | $3.88M | Sell |
8,367
-7,715
| -48% | -$3.57M | 0.02% | 555 |
|
|
2013
Q4 | $5.53M | Buy |
+16,082
| New | +$5.53M | 0.02% | 473 |
|